Market Overview

Mid-Morning Market Update: Markets Open Higher; Pfizer Earnings Miss Views


Following the market opening Tuesday, the Dow traded up 0.5% to 28677.15 while the NASDAQ rose 0.86% to 9217.79. The S&P also rose, gaining 0.77% to 3,268.55.

Leading and Lagging Sectors

Information technology shares climbed 1% on Tuesday. Meanwhile, top gainers in the sector included Servicesource International Inc (NASDAQ: SREV), up 8%, and Sprout Social Inc (NASDAQ: SPT), up 5%.

In trading on Tuesday, industrial shares rose by just 0.2%.

Top Headline

Pfizer Inc. (NYSE: PFE) reported weaker-than-expected results for its fourth quarter.

Pfizer reported quarterly earnings of $0.55 per share, which missed the analyst consensus estimate of 57 cents. The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion.

Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.

Equities Trading UP

Armata Pharmaceuticals, Inc. (NYSE: ARMP) shares shot up 109% to $5.83. Armata Pharmaceuticals and Innoviva reported a $25 million strategic investment to support advancement of Armata's bacteriophage development programs.

Shares of Delphi Technologies PLC (NYSE: DLPH) got a boost, shooting up 63% to $15.92 after the company announced it will be acquired by BorgWarner for $3.3 billion in an all-stock transaction.

Acceleron Pharma Inc. (NASDAQ: XLRN) shares were also up, gaining 52% to $80.20 following a data readout. Acceleron said a Phase 2 study dubbed PULSAR that evaluated its sotatercept in patients with pulmonary arterial hypertension, or PAH, met its primary and key secondary endpoints. The experimental drug showed a statistically significant reduction in pulmonary vascular resistance – the primary endpoint - at week 24 versus placebo. The study also achieved the key secondary endpoint of significant improvements in six-minute walk distance, and other secondary endpoints, including amino-terminal brain natriuretic propeptide, and WHO functional class. It was also found to be generally well tolerated.

Equities Trading DOWN

NanoViricides, Inc. (NYSE: NNVC) shares tumbled 31% to $10.87 after surging 86.98% on Monday.

Shares of TESSCO Technologies Incorporated (NASDAQ: TESS) were down 25% to $9.07 after the company reported downbeat Q3 results.

Allied Healthcare Products, Inc. (NASDAQ: AHPI) was down, falling 23% to $3.3547 after surging 50% on Monday.


In commodity news, oil traded down 0.1% to $53.07, while gold traded down 0.1% to $1,577.20.

Silver traded down 0.4% Tuesday to $17.985, while copper fell 0.3% to $2.5885.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.1%, the Spanish Ibex Index rose 0.5%, while Italy’s FTSE MIB Index rose 1.1% Meanwhile, the German DAX dropped 0.1%, and the French CAC 40 rose 0.2% while UK shares rose 0.3%.


The Federal Open Market Committee will begin its two-day policy meeting today.

U.S. durable goods orders rose 2.4% in December, versus a revised 3.1% decline in the previous month.

The Johnson Redbook Retail Sales Index rose 0.1% during the first three weeks of January versus December.

The S&P Corelogic Case-Shiller home price index climbed 2.6% year-over-year in November, compared to a 2.2% rise in the previous month.

The Treasury is set to auction 52-week bills at 11:30 a.m. ET.

The Treasury will auction 7-year notes at 1:00 p.m. ET.


Related Articles (AHPI + ARMP)

View Comments and Join the Discussion!

Posted-In: Mid-Morning Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at